Cargando…

Absence of ras Mutations and Low Incidence of p53 Mutations in Renal Cell Carcinomas Induced by Ferric Nitrilotriacetate

Renal cell carcinomas induced in male Wistar rats by iron chelate of nitrilotriacetate (Fe‐NTA) were examined for mutations in ras oncogenes and p53 tumor suppressor gene. Fourteen primary tumors and two metastatic tumors from 11 animals were evaluated. Exons 1 and 2 of the H‐, K‐, and N‐ras genes w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akiyama, Takashi, Hamazaki, Shuji, Okada, Shigeru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1995
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920661/ https://www.ncbi.nlm.nih.gov/pubmed/8636002 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03307.x

Ejemplares similares

Astaxanthin ameliorates ferric nitrilotriacetate-induced renal oxidative injury in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2017)

Sex Hormone‐dependent Renal Cell Carcinogenesis Induced by Ferric Nitrilotriacetate in Wistar Rats
por: Deguchi, Jiro, et al.
Publicado: (1995)

Low Incidence of Point Mutations in H‐, K‐ and N‐ras Oncogenes and p53 Tumor Suppressor Gene in Renal Cell Carcinoma and Peritoneal Mesothelioma of Wistar Rats Induced by Ferric Nitrilotriacetate
por: Nishiyama, Yasuyuki, et al.
Publicado: (1995)

Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2012)

Transforming Growth Factor‐α Expression of Renal Proximal Tubules in Wistar Rats Treated with Ferric and Aluminum Nitrilotriacetate
por: Deguchi, Jiro, et al.
Publicado: (1993)

A Beverage Containing Fermented Black Soybean Ameliorates Ferric Nitrilotriacetate-Induced Renal Oxidative Damage in Rats
por: Okazaki, Yasumasa, et al.
Publicado: (2010)

Prevention by 2‐Mercaptoethane Sulfonate and N‐Acetylcysteine of Renal Oxidative Damage in Rats Treated with Ferric Nitrilotriacetate
por: Umemura, Takashi, et al.
Publicado: (1996)

The Role of Ferric Nitrilotriacetate in Renal Carcinogenesis and Cell Death: From Animal Models to Clinical Implications
por: Okazaki, Yasumasa
Publicado: (2022)

Increase in the 8-hydroxyguanine repair activity in the rat kidney after the administration of a renal carcinogen, ferric nitrilotriacetate.
por: Yamaguchi, R, et al.
Publicado: (1996)

Overexpression of Integrin–associated Protein (CD47) in Rat Kidney Treated with a Renal Carcinogen, Ferric Nitrilotriacetate
por: Nishiyama, Yasuyuki, et al.
Publicado: (1997)

Protection by αG‐Rutin, a Water‐soluble Antioxidant Flavonoid, against Renal Damage in Mice Treated with Ferric Nitrilotriacetate
por: Shimoi, Kayoko, et al.
Publicado: (1997)

Infrequent ras Mutation in Human Stomach Cancers
por: Koshiba, Masahiro, et al.
Publicado: (1993)

Zanthoxylum heitzii Modulates Ferric Nitrilotriacetate-Dependent Oxidative Alterations in Four Vital Organs: An In Vitro Organoprotective Model
por: Joël Essogo, Jacques, et al.
Publicado: (2017)

Nephroprotective effect of green tea, rosmarinic acid and rosemary on N-diethylnitrosamine initiated and ferric nitrilotriacetate promoted acute renal toxicity in Wistar rats
por: EL-DESOUKY, Mohamed A., et al.
Publicado: (2019)

Biomolecular Interaction Studies Between Cytochrome PpcA From Geobacter sulfurreducens and the Electron Acceptor Ferric Nitrilotriacetate (Fe-NTA)
por: Ferreira, Marisa R., et al.
Publicado: (2018)

Cloning of the Rat Homologue of the von Hippel‐Lindau Tumor Suppressor Gene and Its Non‐somatic Mutation in Rat Renal Cell Carcinomas
por: Kikuchi, Yasushi, et al.
Publicado: (1995)

Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats.
por: Okada, S., et al.
Publicado: (1989)

Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours.
por: Suchy, B., et al.
Publicado: (1998)

In vitro organo-protective effect of bark extracts from Syzygium guineense var macrocarpum against ferric-nitrilotriacetate-induced stress in wistar rats homogenates
por: Tankeu, Francine Nzufo, et al.
Publicado: (2016)

Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma
por: Tsuda, Hitoshi, et al.
Publicado: (1989)

Microsatellite Instability and k‐ras, p53 Mutations in Thyroid Lymphoma
por: Takakuwa, Tetsuya, et al.
Publicado: (2000)

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
por: Miller, Mark Steven, et al.
Publicado: (2012)

Structure of nitrilotriacetate monooxygenase component B from Mycobacterium thermoresistibile
por: Zhang, Y., et al.
Publicado: (2011)

Biosensors Based on the Binding Events of Nitrilotriacetic Acid–Metal Complexes
por: Zhu, Lin, et al.
Publicado: (2023)

Mutational status of K- ras and TP53 genes in primary sarcomas of the heart
por: Garcia, J M, et al.
Publicado: (2000)

Mutations of RAS genes in endometrial polyps
por: Takeda, Takashi, et al.
Publicado: (2019)

The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck.
por: Clark, L. J., et al.
Publicado: (1993)

Complete Genome Sequence of Nitrilotriacetate-Degrading Aminobacter aminovorans KCTC 2477(T)
por: Lee, Sang-Heon, et al.
Publicado: (2016)

Nitrilotriacetic Acid Improves Plasma Electrolytic Oxidation of Titanium for Biomedical Applications
por: Kyrylenko, Sergiy, et al.
Publicado: (2023)

Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
por: Campos, Manuel António, et al.
Publicado: (2020)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

Tumor Protein p53 and K -ras Gene Mutations in Peruvian Patients with Gallbladder Cancer
por: Vidaurre, Tatiana, et al.
Publicado: (2019)

Lower Incidence of K‐ras Codon 12 Mutation in Flat Colorectal Adenomas than in Polypoid Adenomas
por: Yamagata, Seiichi, et al.
Publicado: (1994)

Detection of ras Gene Mutations in Perioperative Peripheral Blood with Pancreatic Adenocarcinoma
por: Nomoto, Shuji, et al.
Publicado: (1996)

Rare Occurrence of ras and p53 Gene Mutations in Mouse Stomach Tumors Induced by N–Methyl–N–nitrosourea
por: Furihata, Chie, et al.
Publicado: (1997)

Absence of ras Family Point Mutations at Codons 12, 13 and 61 in N‐Ethyl‐N‐hydroxyethylnitrosamine‐ or N‐Nitrosomorpholine‐induced Renal Cell Tumors in Rats
por: Matsumoto, Kazuyuki, et al.
Publicado: (1992)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS Mutation in Mucinous Carcinoma of the Ovary
por: Panyavaranant, Pinyada, et al.
Publicado: (2019)

Ras protein abundance correlates with Ras isoform mutation patterns in cancer
por: Hood, Fiona E., et al.
Publicado: (2023)

Catalytic Properties of Two Complexes of chromium(III) and cobalt(II) with Nitrilotriacetate, Dipicolinate, and 4-Acetylpyridine
por: Malinowski, Jacek, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fr4oaq4nl97blt753rh4jhje3b